ribociclib,palbociclib
novartis,pfizer
['bcsm', 'mbc', 'ribociclib', 'palbociclib']
great presentation by - maintaining cdk4/6-inhibition (#ribociclib) after progression &amp; switching the et partner doubled pfs in hr+ mbc patients. however, it s important to highlight that 87% of pts had received prior #palbociclib #bcsm #asco2022 #asco22 
Medical Oncologist and scholar at Hospital Sírio-Libanês #brasilia. #Breastcancer  #Immunotherapy #clinicalresearch. Tweets are my own not medical advice.